BACKGROUND: The reinforcing effects of nicotine are mediated by brain regions that also support temporal difference error (TDE) processing; yet, the impact of nicotine on TDE is undetermined. METHODS:Dependent smokers (n = 21) and matched control subjects (n = 21) weretrained to associate a juice reward with a visual cue in a classical conditioning paradigm. Subjects subsequently underwent functional magnetic resonance imaging sessions in which they were exposed to trials where they either received juice as temporally predicted or where the juice was withheld (negative TDE) and later received unexpectedly (positive TDE). Subjects were scanned in two sessions that were identical, except that smokers had a transdermal nicotine (21 mg) or placebo patch placed before scanning. Analysis focused on regions along the trajectory of mesocorticolimbic and nigrostriatal dopaminergic pathways. RESULTS: There was a reduction in TDE-related function in smokers in the striatum, which did not differ as a function of patch manipulation but was predicted by the duration (years) of smoking. Activation in midbrain regions was not impacted by group or drug condition. CONCLUSIONS: These data suggest a differential effect of smoking status on the neural substrates of reward in distinct dopaminergic pathway regions, which may be partially attributable to chronic nicotine exposure. The failure of transdermal nicotine to alter reward-related functional processes, either within smokers or between smokers and control subjects, implies that acute nicotine patch administration is insufficient to modify reward processing, which has been linked to abstinence-induced anhedonia in smokers and may play a critical role in smoking relapse.
RCT Entities:
BACKGROUND: The reinforcing effects of nicotine are mediated by brain regions that also support temporal difference error (TDE) processing; yet, the impact of nicotine on TDE is undetermined. METHODS: Dependent smokers (n = 21) and matched control subjects (n = 21) were trained to associate a juice reward with a visual cue in a classical conditioning paradigm. Subjects subsequently underwent functional magnetic resonance imaging sessions in which they were exposed to trials where they either received juice as temporally predicted or where the juice was withheld (negative TDE) and later received unexpectedly (positive TDE). Subjects were scanned in two sessions that were identical, except that smokers had a transdermal nicotine (21 mg) or placebo patch placed before scanning. Analysis focused on regions along the trajectory of mesocorticolimbic and nigrostriatal dopaminergic pathways. RESULTS: There was a reduction in TDE-related function in smokers in the striatum, which did not differ as a function of patch manipulation but was predicted by the duration (years) of smoking. Activation in midbrain regions was not impacted by group or drug condition. CONCLUSIONS: These data suggest a differential effect of smoking status on the neural substrates of reward in distinct dopaminergic pathway regions, which may be partially attributable to chronic nicotine exposure. The failure of transdermal nicotine to alter reward-related functional processes, either within smokers or between smokers and control subjects, implies that acute nicotine patch administration is insufficient to modify reward processing, which has been linked to abstinence-induced anhedonia in smokers and may play a critical role in smoking relapse.
Authors: Raad Nashmi; Cheng Xiao; Purnima Deshpande; Sheri McKinney; Sharon R Grady; Paul Whiteaker; Qi Huang; Tristan McClure-Begley; Jon M Lindstrom; Cesar Labarca; Allan C Collins; Michael J Marks; Henry A Lester Journal: J Neurosci Date: 2007-08-01 Impact factor: 6.167
Authors: Sarah E McCallum; Neeraja Parameswaran; Tanuja Bordia; Hong Fan; Rachel F Tyndale; J William Langston; J Michael McIntosh; Maryka Quik Journal: J Neurochem Date: 2006-01-12 Impact factor: 5.372
Authors: Megan E Piper; Danielle E McCarthy; Daniel M Bolt; Stevens S Smith; Caryn Lerman; Neal Benowitz; Michael C Fiore; Timothy B Baker Journal: Nicotine Tob Res Date: 2008-06 Impact factor: 4.244
Authors: Elise Lesage; Sarah E Aronson; Matthew T Sutherland; Thomas J Ross; Betty Jo Salmeron; Elliot A Stein Journal: JAMA Psychiatry Date: 2017-06-01 Impact factor: 21.596
Authors: Emma Jane Rose; Betty Jo Salmeron; Thomas J Ross; James Waltz; Julie B Schweitzer; Samuel M McClure; Elliot A Stein Journal: Neuropsychopharmacology Date: 2014-01-29 Impact factor: 7.853
Authors: Muhammad A Parvaz; Anna B Konova; Greg H Proudfit; Jonathan P Dunning; Pias Malaker; Scott J Moeller; Tom Maloney; Nelly Alia-Klein; Rita Z Goldstein Journal: J Neurosci Date: 2015-02-04 Impact factor: 6.167